Sonoma Pharmaceuticals Ownership | Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals Ownership Summary

Sonoma Pharmaceuticals is owned by 2.79% institutional investors, 1.51% insiders, and 95.70% retail investors. Citadel advisors is the largest institutional shareholder, holding 1.25% of SNOA shares. Fidelity Extended Market Index is the top mutual fund, with 0.41% of its assets in Sonoma Pharmaceuticals shares.

SNOA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sonoma Pharmaceuticals	2.79%	1.51%	95.70%
Sector	Healthcare Stocks	46.62%	8.13%	45.25%
Industry	Specialty & Generic Drug Manufacturers Stocks	32.73%	9.50%	57.78%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Citadel advisors	195.16K	1.25%	$41.41K
Geode capital management	86.64K	0.56%	$18.39K
State street	24.32K	0.16%	$5.16K
Ubs group	11.92K	0.08%	$2.53K
Blackrock	2.27K	0.01%	$481.00
Bank of america corp /de/	172.00	0.00%	$36.00
Morgan stanley	86.00	0.00%	$18.00
Wells fargo & company/mn	33.00	0.00%	$7.00
Millennium management	-	-	-
Us bancorp \de\	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Geode capital management	86.64K	-	$18.39K
Blackrock	2.27K	-	$481.00
Tower research capital llc (trc)	-	-	-
Two sigma securities	-	-	-
Susquehanna group, llp	-	-	-
Advisor group	-	-	-
Bank of america corp /de/	172.00	-	$36.00
Jane street group	-	-	-
Millennium management	-	-	-
Us bancorp \de\	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	195.16K	-	195.16K
Geode capital management	86.64K	-	50.86K
Ubs group	11.92K	-	11.81K
Bank of america corp /de/	172.00	-	128.00
Blackrock	2.27K	-	-

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	-	-	-46.05K
Jane street group	-	-	-45.30K
Hrt financial lp	-	-	-21.52K
Xtx topco	-	-	-19.83K
Two sigma securities	-	-	-15.32K

Sold Out

Holder	Change
Allworth financial lp	-65.00
Advisor group	-200.00
Us bancorp \de\	-500.00
Qube research	-3.40K
Tower research capital llc (trc)	-8.27K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	17	21.43%	434,996	164.81%	2	122.92%	10	100.00%	2	-
Mar 31, 2024	14	-12.50%	164,265	-45.93%	1	19.42%	5	-37.50%	2	-
Dec 31, 2023	16	33.33%	303,776	141.45%	2	42.86%	8	300.00%	2	-50.00%
Sep 30, 2023	12	-20.00%	125,814	-22.31%	2	11.20%	2	-33.33%	4	33.33%
Jun 30, 2023	15	-11.76%	161,945	10.38%	4	21.40%	3	-57.14%	3	50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	5.44K	0.41%	591.00
Fidelity Series Total Market Index	1.26K	0.09%	1.18K
Fidelity Nasdaq Composite Index	248.00	0.02%	-
Vanguard Institutional Extnd Mkt Idx Tr	190.00	0.01%	-1.00
Northern Trust Extended Eq Market Idx	96.00	0.01%	-
NT Ext Equity Mkt Idx Fd - L	96.00	0.01%	-
Northern Trust Wilshire 5000	17.00	0.00%	-1.00
NT US Market Cap Idx Fd - L	355.00	0.00%	-
NT Ext Eq Mkt Indx Fd DC Lending Tier 5	15.00	0.00%	-
NT Ext Equity Mkt Idx Fd - NL	13.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.84K
Mar 13, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.92K
Mar 12, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.84K
Mar 09, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.68K
Mar 08, 2018	Schutz James J	Chief Executive Officer	Buy	$9.87K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2023 Q4	-	-
2023 Q3	-	-
2023 Q2	-	-
2022 Q4	-	-

SNOA Ownership FAQ

Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals shareholders are primarily institutional investors at 2.79%, followed by 1.51% insiders and 95.70% retail investors. The average institutional ownership in Sonoma Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 32.73%, which Sonoma Pharmaceuticals falls below.

Who owns the most shares of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals’s largest shareholders are Citadel advisors (195.16K shares, 1.25%), Geode capital management (86.64K shares, 0.56%), and State street (24.32K shares, 0.16%). Together, they hold 1.96% of Sonoma Pharmaceuticals’s total shares outstanding.

Does Blackrock own Sonoma Pharmaceuticals?

Yes, BlackRock owns 0.01% of Sonoma Pharmaceuticals, totaling 2.27K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 481$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Geode capital management is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 86.64K Sonoma Pharmaceuticals shares, valued at 18.38K$.

Who is the top mutual fund holder of Sonoma Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Sonoma Pharmaceuticals shares, with 0.41% of its total shares outstanding invested in 5.44K Sonoma Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools